| Schedule of key management remuneration |
Executive directors’ remuneration and benefits | | | | | | | | | | | | | | | | | | | S Baloyi4 | | WP Bruns4,5 | | VD Kahla | | HA Rossouw6 | | | 2026 | | 2025 | | 2026 | | 2025 | | 2026 | | 2025 | | 2026 | | 2025 | Executive Directors | | R’000 | | R’000 | | R’000 | | R’000 | | R’000 | | R’000 | | R’000 | | R’000 | Salary | | 16 293 | | 12 514 | | 7 608 | | 5 982 | | 8 793 | | 8 499 | | — | | 1 336 | Risk and Retirement funding | | 1 590 | | 1 276 | | 1 002 | | 788 | | 404 | | 382 | | — | | 151 | Vehicle benefit | | 300 | | 300 | | — | | — | | — | | — | | — | | — | Healthcare | | 192 | | 160 | | 187 | | 147 | | 158 | | 147 | | — | | — | Other benefits1 | | 271 | | 96 | | 50 | | 17 | | 676 | | 606 | | — | | — | Total salary and benefits | | 18 646 | | 14 346 | | 8 847 | | 6 934 | | 10 031 | | 9 634 | | — | | 1 487 | Annual short-term incentive2 | | 20 721 | | 11 213 | | 7 454 | | 3 984 | | 6 546 | | 4 360 | | — | | — | Long-term incentive gains3 | | 3 499 | | 353 | | 3 990 | | 387 | | 11 117 | | 3 569 | | — | | — | Total annual remuneration* | | 42 866 | | 25 912 | | 20 291 | | 11 305 | | 27 694 | | 17 563 | | — | | 1 487 |
*The total annual remuneration of the executive directors for 2024 was R54,6 million. | 1 | Other Benefits include security services, long service awards, private travel and other once off costs on which fringe benefit tax is levied where required. |
| 2 | Short-term incentives approved based on the Group results for 2026 and payable in the 2027 financial year. Incentives are calculated as a percentage of total guaranteed package/base salary as at 30 June 2026 x role category % x [(Group STI achievement x 80%) + (Individual Performance Achievement x 20%) – fatality penalty]. |
| 3 | Long-term incentives gains for 2026 includes the Renewable energy (RE) grant awards made during financial year 2021 (where measurement was postponed to a day no later than 31 December 2026), the annual and retention (Mr Bruns) awards made in August 2023 and EVP Restricted (RLTI) award made in September 2021. The illustrative amount is calculated in terms of the number of LTIs x Corporate performance target achieved where relevant (RLTI and RE: 100%; Performance GEC: 72%) x June 2026 average share price. The actual vesting date for the awards is between 28 August 2026 and 27 September 2026 subject to the company being in an open period. Dividend equivalents accrue at the end of the vesting period, to the extent that the LTIs vest. 50% of the vested LTIs and accrued dividends will be released in 2026 and the balance in 2028, subject to the rules of the LTI plan. As there are no further performance conditions attached to the balance of the 50%, the full amount is disclosed in the total earned remuneration table. |
| 4 | The Remuneration Committee approved market-related salary adjustments, where appropriate and in line with the Policy, in addition to annual salary increases, to support the continued competitiveness of the Group’s remuneration structure. |
| 5 | Mr Bruns was appointed as CFO from 1 September 2024. The disclosed prior year remuneration is thus apportioned. |
| 6 | Mr Rossouw stepped down as executive director and CFO effective 31 August 2024. All unvested LTIs were forfeited upon his resignation. |
| | | | | | | | | | | | | Executive directors’ unvested LTI holdings (number and intrinsic value) for 2026 | | | | | | | | | | | | | | | | S Baloyi | | WP Bruns | | VD Kahla | | | | | Intrinsic | | | | Intrinsic | | | | Intrinsic | | | Number | | value1 | | Number | | value1 | | Number | | value1 | Executive Directors | | | | R’000 | | | | R’000 | | | | R’000 | Balance at beginning of the year* | | 217 518 | | 17 132 | | 167 758 | | 13 213 | | 222 776 | | 17 546 | Awards granted2 | | 185 812 | | 23 275 | | 85 680 | | 10 732 | | 82 511 | | 10 335 | Change in value1 | | — | | 24 162 | | — | | 16 579 | | — | | 17 933 | Effect of corporate performance targets | | (1 116) | | (155) | | (324) | | (45) | | (3 001) | | (418) | Dividend equivalents | | 1 129 | | 157 | | 1 821 | | 254 | | 9 570 | | 1 333 | Awards settled3 | | (11 734) | | (1 263) | | (11 323) | | (1 351) | | (66 571) | | (7 076) | Balance at the end of the year4 | | 391 609 | | 63 308 | | 243 612 | | 39 382 | | 245 285 | | 39 653 |
*The total intrinsic value of the executive directors' unvested LTI holdings for 2024 was R46,5 million. | 1 | Intrinsic values at the beginning and end of the year have been determined using the closing price of: |
30 June 2026 R161,66 30 June 2025 R78,76 Change in intrinsic value for the year results from changes in the share price. | 2 | LTIs granted on 8 September 2025. |
| 3 | Long-term incentives settled represent long-term incentives that vested with reference to the group results for 2025 that was settled in the 2026 financial year. The full amount of the remaining 50% that vested in the current year is disclosed in the total earned remuneration table. It also included the second tranche of awards which vested in 2023(on which there were no further performance conditions) and the restricted awards, both granted in 2020. The difference between the long-term incentive gains disclosed in 2025 and the amount settled in 2026 is due to difference in actual share price at vesting date and the share price at date of disclosure. |
| 4 | The balance includes 22 761 awards granted in 2021, with the associated renewable energy CPT deferred to 31 December 2026. |
Prescribed Officers’ remuneration and benefits | | | | | | | | | | | | | | | | | | | V Bester4 | | AGM Gerber5 | | C Herrmann5,6 | | AT Makgala7 | | | 2026 | | 2025 | | 2026 | | 2025 | | 2026 | | 2025 | | 2026 | | 2025 | Prescribed Officers | | R’000 | | R’000 | | R’000 | | R’000 | | R’000 | | R’000 | | R’000 | | R’000 | Salary | | 7 156 | | 6 044 | | 10 186 | | 9 375 | | 8 118 | | 7 969 | | 4 433 | | — | Risk and Retirement funding | | 1 086 | | 920 | | 796 | | 873 | | 645 | | 595 | | 762 | | — | Vehicle benefit | | — | | — | | 146 | | 308 | | 248 | | 252 | | — | | — | Healthcare | | 130 | | 121 | | 115 | | 104 | | 230 | | 224 | | 55 | | — | Other benefits1 | | 112 | | 100 | | 41 | | 217 | | 3 772 | | 2 634 | | 11 352 | | — | Total salary and benefits | | 8 484 | | 7 185 | | 11 284 | | 10 877 | | 13 013 | | 11 674 | | 16 602 | | — | Annual short-term incentive2 | | 6 578 | | 3 549 | | 7 389 | | 4 867 | | 5 355 | | 3 894 | | 3 550 | | — | Long-term incentive gains3 | | 2 110 | | 119 | | — | | — | | 3 824 | | 637 | | — | | — | Total annual remuneration* | | 17 172 | | 10 853 | | 18 673 | | 15 744 | | 22 192 | | 16 205 | | 20 152 | | — |
*The total annual remuneration of the prescribed officers for 2024 was R97,2 million. | 1 | Other Benefits include security services, long service awards, private travel and other once off costs on which fringe benefit tax is levied where required. |
| 2 | Short-term incentives approved based on the Group results for 2026 and payable in the 2027 financial year. Incentives are calculated as a percentage of total guaranteed package/base salary as at 30 June 2026 x role category % x [(Group STI achievement x 80%) + (Individual Performance Achievement x 20%) – fatality penalty]. |
| 3 | Long-term incentives gains for 2026 includes the Renewable energy (RE) grant awards made during financial year 2021 (where measurement was postponed to a day no later than 31 December 2026), the annual and on-appointment awards made in 2023 and EVP Restricted (RLTI) award made in September 2021. The illustrative amount is calculated in terms of the number of LTIs x Corporate performance target achieved where relevant (RLTI and RE: 100%; Performance GEC: 72%; SVP: 80,4%) x June 2026 average share price. The actual vesting date for the awards is between 28 August 2026 and 27 September 2026 subject to the company being in an open period. Dividend equivalents accrue at the end of the vesting period, to the extent that the LTIs vest. 50% of the vested LTIs and accrued dividends will be released in 2026 and the balance in 2028, subject to the rules of the LTI plan. As there are no further performance conditions attached to the balance of the 50%, the full amount is disclosed in the total earned remuneration table. |
| 4 | The Remuneration Committee approved market-related salary adjustments, where appropriate and in line with the Policy, in addition to annual salary increases, to support the continued competitiveness of the Group's remuneration structure. |
| 5 | Ms Gerber and Mr Herrmann are employed on German employment contracts and paid in Euros. The conversion to Rand has been done using the monthly average of daily closing rates. |
| 6 | Expatriate benefits in South Africa are offered and grossed up as appropriate. Other Benefits include accommodation, home leave allowance and transportation offered under the Expatriation policy. |
| 7 | Ms Makgala was appointed as EVP: People, SHE, Risk and Corporate Affairs on 1 October 2025. Other Benefits include a staggered buy-out arrangement in respect of incentives forfeited (R5,4 million) when she resigned from her previous employer as well as relocation expenses (R0,4 million) paid in terms of the policy. A non-taxable payment to her previous employer with respect to a work-back agreement is included in the amount to the value of R5,4 million. The Sasol buy-out agreement for all payments is linked to a work-back period. |
| | | | | | | | | | | | | | | | | | | CK Mokoena4 | | SD Pillay5 | | S Siyaya6 | | H Wenhold7 | | | 2026 | | 2025 | | 2026 | | 2025 | | 2026 | | 2025 | | 2026 | | 2025 | Prescribed Officers | | R'000 | | R'000 | | R’000 | | R’000 | | R’000 | | R’000 | | R’000 | | R’000 | Salary | | 1 821 | | 6 915 | | 6 011 | | 5 039 | | 4 598 | | — | | 1 192 | | 6 288 | Risk and Retirement funding | | — | | 327 | | 939 | | 795 | | 536 | | — | | — | | 824 | Vehicle benefit | | — | | — | | 150 | | 150 | | — | | — | | — | | — | Healthcare | | 45 | | 174 | | 130 | | 121 | | 158 | | — | | 21 | | 121 | Other benefits1 | | 10 | | 72 | | 61 | | 11 | | 11 | | — | | 5 | | 34 | Total salary and benefits | | 1 876 | | 7 488 | | 7 291 | | 6 116 | | 5 303 | | — | | 1 218 | | 7 267 | Annual short-term incentive2 | | 3 503 | | 3 637 | | 5 190 | | 3 072 | | 3 374 | | — | | 4 369 | | 3 439 | Long-term incentive gains3 | | 7 168 | | 2 931 | | 503 | | 947 | | 2 642 | | — | | 6 917 | | 671 | Total annual remuneration* | | 12 547 | | 14 056 | | 12 984 | | 10 135 | | 11 319 | | — | | 12 504 | | 11 377 |
*The total annual remuneration of the prescribed officers for 2024 was R97,2 million. | 1 | Other Benefits include security services, long service awards, private travel and other once off costs on which fringe benefit tax is levied where required. |
| 2 | Short-term incentives approved based on the Group results for 2026 and payable in the 2027 financial year. Incentives are calculated as a percentage of total guaranteed package/base salary as at 30 June 2026 x role category % x [(Group STI achievement x 80%) + (Individual Performance Achievement x 20%) – fatality penalty]. |
| 3 | Long-term incentives gains for 2026 includes the Renewable energy (RE) grant awards made during financial year 2021 (where measurement was postponed to a day no later than 31 December 2026), the annual and on-appointment awards made in 2023 and EVP Restricted (RLTI) award made in September 2021. The illustrative amount is calculated in terms of the number of LTIs x Corporate performance target achieved where relevant (RLTI and RE: 100%; Performance GEC: 72%; SVP: 80,4%) x June 2026 average share price. The actual vesting date for the awards is between 28 August 2026 and 27 September 2026 subject to the company being in an open period. Dividend equivalents accrue at the end of the vesting period, to the extent that the LTIs vest. 50% of the vested LTIs and accrued dividends will be released in 2026 and the balance in 2028, subject to the rules of the LTI plan. As there are no further performance conditions attached to the balance of the 50%, the full amount is disclosed in the total earned remuneration table. |
| 4 | Ms Mokoena stepped down as prescribed officer on 30 September 2025 after reaching the Sasol retirement age for group executives. |
| 5 | The Remuneration Committee approved market-related salary adjustments, where appropriate and in line with the Policy, in addition to annual salary increases, to support the continued competitiveness of the Group's remuneration structure. |
| 6 | Mr Siyaya was appointed as EVP: Mining on 1 September 2025. Remuneration is disclosed for the period since appointment. |
| 7 | Mr Wenhold stepped down as a prescribed officer on 31 August 2025 after reaching the Sasol retirement age for group executives. |
Prescribed Officers’ unvested LTI holdings (number and intrinsic value) for 2026 | | | | | | | | | | | | | | | | | | | V Bester | | AGM Gerber | | C Herrmann | | AT Makgala5 | | | | | Intrinsic | | | | Intrinsic | | | | Intrinsic | | | | Intrinsic | | | Number | | value1 | | Number | | value1 | | Number | | value1 | | Number | | value1 | Prescribed Officers | | | | R'000 | | | | US$’000 | | | | US$'000 | | | | R’000 | Balance at beginning of the year* | | 77 615 | | 6 113 | | 85 378 | | 377 | | 122 021 | | 539 | | — | | — | Awards granted2 | | 66 132 | | 8 284 | | 93 110 | | 666 | | 74 488 | | 533 | | 64 863 | | 7 219 | Change in value1 | | — | | 8 795 | | — | | 710 | | — | | 805 | | — | | 3 267 | Effect of corporate performance targets | | (100) | | (14) | | — | | — | | (574) | | (5) | | — | | — | Dividend equivalents | | 528 | | 74 | | — | | — | | 2 529 | | 21 | | — | | — | Awards settled3 | | (1 511) | | (189) | | — | | — | | (19 674) | | (137) | | — | | — | Balance at the end of the year4 | | 142 664 | | 23 063 | | 178 488 | | 1 753 | | 178 790 | | 1 756 | | 64 863 | | 10 486 |
*The total intrinsic value of the prescribed officers' unvested LTI holdings for 2024 was R38,4 million. | 1 | Intrinsic values at the beginning and end of the year have been determined using the closing price of: |
30 June 2026 R161,66 ($9,82) 30 June 2025 R78,76 ($4,42) Change in intrinsic value for the year results from changes in the share price. | 2 | LTIs granted on 8 September 2025 and 28 November 2025. |
| 3 | Long-term incentives settled represent long-term incentives that vested with reference to the group results for 2025 that was settled in the 2026 financial year. The full amount of the remaining 50% that vested in the current year is disclosed in the total earned remuneration table. It also included the second tranche of awards which vested in 2023(on which there were no further performance conditions) and the restricted awards, both granted in 2020.The difference between the long-term incentive gains disclosed in 2025 and the amount settled in 2026 is due to difference in actual share price at vesting date and the share price at date of disclosure. |
| 4 | The balance includes 2 333 awards granted in 2021, with the associated renewable energy CPT deferred to 31 December 2026. |
| 5 | Ms Makgala was appointed on 1 October 2025 as EVP: People, SHE, Risk and Corporate Affairs. |
| | | | | | | | | | | | | | | | | | | CK Mokoena5 | | S Pillay | | S Siyaya6 | | H Wenhold7 | | | Number | | Intrinsic value1 | | Number | | Intrinsic value1 | | Number | | Intrinsic value1 | | Number | | Intrinsic value1 | Prescribed Officers | | | | R’000 | | | | R’000 | | | | R’000 | | | | R’000 | Balance at beginning of the year* | | 162 969 | | 12 835 | | 69 031 | | 5 437 | | — | | — | | 123 098 | | 9 695 | Awards granted2 | | — | | — | | 56 376 | | 7 062 | | 57 684 | | 7 225 | | — | | — | Change in value1 | | — | | 4 678 | | — | | 7 860 | | — | | 3 847 | | — | | 4 710 | Effect of corporate performance targets | | — | | — | | (569) | | (79) | | (38) | | (5) | | — | | — | Dividend equivalents | | — | | — | | 1 467 | | 204 | | 238 | | 33 | | — | | — | Awards settled3 | | — | | — | | (9 285) | | (1 567) | | (1 125) | | (141) | | — | | — | Effect of changes in Prescribed Officers | | (162 969) | | (17 513) | | — | | — | | 39 958 | | 4 676 | | (123 098) | | (14 405) | Balance at the end of the year4 | | — | | — | | 117 020 | | 18 917 | | 96 717 | | 15 635 | | — | | — |
*The total intrinsic value of the prescribed officers' unvested LTI holdings for 2024 was R38,4 million. | 1 | Intrinsic values at the beginning and end of the year have been determined using the closing price of: |
30 June 2026 R161,66 30 June 2025 R78,76 Change in intrinsic value for the year results from changes in the share price. | 2 | LTIs granted on 8 September 2025 and 28 November 2025. |
| 3 | Long-term incentives settled represent long-term incentives that vested with reference to the group results for 2025 that was settled in the 2026 financial year. The full amount of the remaining 50% that vested in the current year is disclosed in the total earned remuneration table. It also included the second tranche of awards which vested in 2023(on which there were no further performance conditions) and the restricted awards, both granted in 2020.The difference between the long-term incentive gains disclosed in 2025 and the amount settled in 2026 is due to difference in actual share price at vesting date and the share price at date of disclosure. |
| 4 | The balance includes 2 333 awards granted in 2021, with the associated renewable energy CPT deferred to 31 December 2026. |
| 5 | Ms Mokoena resigned from Sasol on 30 September 2025. |
| 6 | Mr Siyaya was appointed on 1 September 2025 as EVP: Mining. |
| 7 | Mr Wenhold resigned from Sasol on 30 August 2025. |
Non-executive Directors’ remuneration | | | | | | | | | | | | | | | | | | | | | | | | | | Lead | | | | | | | | | Board | | independent | | | | | | | | | meeting | | Director | | Committee | | Total1 | | Total1 | | | fees2 | | fees2 | | fees2 | | 2026 | | 2025 | Non-executive Directors | | R'000 | | R'000 | | R'000 | | R'000 | | R'000 | MBN Dube (Chairman) | | 6 385 | | — | | — | | 6 385 | | 6 671 | M Flöel (Lead Independent Director)3 | | 2 077 | | 964 | | 1 248 | | 4 289 | | 4 234 | KC Harper4 | | 1 463 | | — | | 458 | | 1 921 | | 3 086 | DGP Eyton5 | | 2 221 | | — | | 1 363 | | 3 584 | | 3 089 | MJ Cuambe6 | | 1 805 | | — | | 845 | | 2 650 | | 2 606 | GMB Kennealy | | 1 958 | | — | | 1 037 | | 2 995 | | 2 982 | S Subramoney | | 1 958 | | — | | 613 | | 2 571 | | 2 564 | NX Maluleke7 | | 2 101 | | — | | 562 | | 2 663 | | — | R Gasant8 | | 803 | | — | | 51 | | 854 | | — | TJ Cumming9 | | — | | — | | — | | — | | 2 917 | NNA Matyumza10 | | — | | — | | — | | — | | 421 | MEK Nkeli11 | | — | | — | | — | | — | | 458 | Total | | 20 771 | | 964 | | 6 177 | | 27 912 | | 29 028 |
| 2 | Board and Committee fees are denominated in US dollars and are therefore subject to fluctuations in foreign exchange rates. For Non-Executive Directors permanently resident outside Europe, the United Kingdom and North America, the Rand/US$ exchange rate applicable to Board and Committee fees was fixed for the first half of 2026 using the average exchange rate for the period July 2023 to December 2024. The exchange rate applicable to the second half of 2026 was fixed using the average exchange rate for the period July 2024 to December 2025. In addition, a cost-of-living adjustment is applied to the fees of these directors. |
To reduce the impact of currency volatility on Non-Executive Directors permanently resident in Europe, the United Kingdom and North America, the US$/EUR and US$/GBP exchange rates applicable to Board and Committee fees were fixed for quarter 2, quarter 3 and quarter 4 using the prevailing average exchange rates at the time the fees were approved. The approved fee values were thereafter converted to US dollars for payment. | 3 | Dr Flöel was appointed as Remuneration Committee Chairman and stepped down from the Capital Investment Committee Chairman role, effective 6 June 2025 while remaining a member of Capital Investment Committee. |
| 4 | Ms Harper resigned from the Board on 16 February 2026 and received pro rated Board and Committee fees for quarter 3. |
| 5 | Mr Eyton stepped down as a member of the Audit and Risk Committee, effective 1 June 2026 and received pro rated committee fees for quarter 4. |
| 6 | Mr Cuambe was appointed as the Chairman of the Capital Investment Committee, on 6 June 2025. He stepped down as a member of the Safety, Social and Ethics Committee on 22 August 2025 and received pro rated committee fees for quarter 1. |
| 7 | Ms Maluleke was appointed to the Board effective 9 June 2025, received Sasol Limited Board fees from 1 July 2025, and was appointed to the Audit and Risk, and Safety, Social and Ethics Committees, on 22 August 2025. |
| 8 | Mr Gasant was appointed to the Board on 1 February 2026 and received a pro-rated Board fee. He was appointed to the Audit and Risk Committee and the Remuneration Committee on 1 June 2026 and received pro rated committee fee payments. |
| 9 | Mr Cumming resigned from the Board on 6 June 2025. |
| 10 | Ms Matyumza retired from the Board on 8 September 2024. |
| 11 | Ms Nkeli retired from the Board on 31 August 2024. |
|